Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
82,244 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Belatacept (Nulojix)PayerPolicy · BCBSNJ-DRUGS-095-5DDEA30204 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Immune Globulin Subcutaneous (Hizentra, Gammagard Liquid, Gamunex-C/Gammaked, HyQvia, Cuvitru, Cutaquig, and Xembify for Subcutaneous Administration)PayerPolicy · BCBSNJ-DRUGS-045-EEF5008B75 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Drug Therapy for Hereditary Angioedema [Cinryze, Berinert, Haegarda (Human C1 Inhibitor), Kalbitor (Ecallantide), Firazyr (Icatibant), Ruconest (C1 Esterase Inhibitor [Recombinant]), Takhzyro (lanadelumab-flyo)]PayerPolicy · BCBSNJ-DRUGS-063-5CE01BD5D5 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Romiplostim (Nplate)PayerPolicy · BCBSNJ-DRUGS-062-1C16239772 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Emapalumab-lzsg (Gamifant)PayerPolicy · BCBSNJ-DRUGS-187-D20745B7A0 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Cemiplimab-rwlc (Libtayo)PayerPolicy · BCBSNJ-DRUGS-185-0D79CE48DB | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Mogamulizumab-kpkc (Poteligeo)PayerPolicy · BCBSNJ-DRUGS-184-9A116BE663 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Patisiran (Onpattro)PayerPolicy · BCBSNJ-DRUGS-182-8171B432A4 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Burosumab-twza (Crysvita)PayerPolicy · BCBSNJ-DRUGS-180-61BD1379FC | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Tildrakizumab (Ilumya)PayerPolicy · BCBSNJ-DRUGS-179-F21120282F | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Arsenic Trioxide (Trisenox)PayerPolicy · BCBSNJ-DRUGS-177-B3FBA7716F | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Axicabtagene Ciloleucel (Yescarta)PayerPolicy · BCBSNJ-DRUGS-164-D00B1DEDA3 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Gemtuzumab Ozogamicin (Mylotarg)PayerPolicy · BCBSNJ-DRUGS-162-BBBC3A9B12 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Liposomal Formulation of Daunorubicin and Cytarabine (Vyxeos)PayerPolicy · BCBSNJ-DRUGS-161-711D747DE6 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Inotuzumab Ozogamicin (Besponsa)PayerPolicy · BCBSNJ-DRUGS-160-912BF20078 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Belinostat (Beleodaq)PayerPolicy · BCBSNJ-DRUGS-159-F54A453407 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Tisagenlecleucel (Kymriah)PayerPolicy · BCBSNJ-DRUGS-158-DD09970816 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Edaravone (Radicava)PayerPolicy · BCBSNJ-DRUGS-156-CCDD6F6F95 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Durvalumab (Imfinzi)PayerPolicy · BCBSNJ-DRUGS-155-AB4ECF3581 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Avelumab (Bavencio)PayerPolicy · BCBSNJ-DRUGS-152-56E55DCC03 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Ocrelizumab (Ocrevus)PayerPolicy · BCBSNJ-DRUGS-150-32F9539D1A | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Probuphine (Buprenorphine) Implant for Subdermal Administration and Sublocade (Buprenorphine Extended-Release) Injection for Subcutaneous UsePayerPolicy · BCBSNJ-DRUGS-145-189E498D85 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Atezolizumab (Tecentriq)PayerPolicy · BCBSNJ-DRUGS-140-27A88AD742 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Fulvestrant (Faslodex)PayerPolicy · BCBSNJ-DRUGS-138-B6A45FA175 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Melphalan (Alkeran and Evomela)PayerPolicy · BCBSNJ-DRUGS-137-E12C5A79AF | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Daratumumab (Darzalex), Daratumumab and hyaluronidase-fihj (Darzalex Faspro)PayerPolicy · BCBSNJ-DRUGS-135-226C88A221 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Elotuzumab (Empliciti)PayerPolicy · BCBSNJ-DRUGS-134-975447F337 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Monoclonal Interleukin-5 Antagonists [mepolizumab (Nucala), reslizumab (Cinqair), and benralizumab (Fasenra)]PayerPolicy · BCBSNJ-DRUGS-133-2ADC519856 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Lemtrada (Alemtuzumab)PayerPolicy · BCBSNJ-DRUGS-127-9B8A5CDC04 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Blinatumomab (Blincyto)PayerPolicy · BCBSNJ-DRUGS-126-DAD4FB2474 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Nivolumab (Opdivo)PayerPolicy · BCBSNJ-DRUGS-125-ED9CBE5AAA | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Pembrolizumab (Keytruda)PayerPolicy · BCBSNJ-DRUGS-124-B81D0CE356 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Levoleucovorin (Fusilev and Khapzory)PayerPolicy · BCBSNJ-DRUGS-122-16CFD1DF59 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Vedolizumab (Entyvio)PayerPolicy · BCBSNJ-DRUGS-121-DECB2B279B | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Siltuximab (Sylvant)PayerPolicy · BCBSNJ-DRUGS-119-DE19AA24C1 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Sandostatin, Sandostatin LAR depot (Octreotide), Somatuline Depo (lanreotide), Signifor LAR (pasireotide)PayerPolicy · BCBSNJ-DRUGS-118-6096E061EB | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Bortezomib (Velcade)PayerPolicy · BCBSNJ-DRUGS-117-4C26E16E4D | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Bendamustine Hydrochloride (Treanda, Bendeka, Belrapzo)PayerPolicy · BCBSNJ-DRUGS-116-EFD9F530EC | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Gazyva (Obinutuzumab)PayerPolicy · BCBSNJ-DRUGS-115-71C22348AD | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Marqibo (Vincristine Sulfate Liposome Injection)PayerPolicy · BCBSNJ-DRUGS-103-9082A872D8 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Carfilzomib (Kyprolis)PayerPolicy · BCBSNJ-DRUGS-102-8C23399B10 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Erwinaze (Asparaginase Erwinia Chrysanthemi), Oncaspar (pegaspargase) and Asparlas (calaspargase pegol-mknl)PayerPolicy · BCBSNJ-DRUGS-100-DF31757ABC | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Brentuximab Vedotin (Adcetris)PayerPolicy · BCBSNJ-DRUGS-097-9DEFDC1DAA | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Oxaliplatin (Eloxatin)PayerPolicy · BCBSNJ-DRUGS-094-12BEA584EF | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Ipilimumab (Yervoy)PayerPolicy · BCBSNJ-DRUGS-089-3FAB84A473 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Belimumab (Benlysta)PayerPolicy · BCBSNJ-DRUGS-088-EC543C5397 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Eribulin Mesylate (Halaven)PayerPolicy · BCBSNJ-DRUGS-086-B8CB10874F | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Pegloticase (Krystexxa)PayerPolicy · BCBSNJ-DRUGS-084-9906016B3D | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Pemetrexed Disodium (Alimta)PayerPolicy · BCBSNJ-DRUGS-083-DCE695AF19 | Codes changed |
|---|
| Aug 22, 2026 | Horizon BCBSNJ | Paclitaxel Protein-Bound Particles (Abraxane)PayerPolicy · BCBSNJ-DRUGS-082-764D03C4F8 | Codes changed |
|---|